CVS Stock Overview
CVS Health Corporation provides health solutions in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 5/6 |
| Financial Health | 2/6 |
| Dividends | 6/6 |
CVS Health Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$4,155.00 |
| 52 Week High | US$5,400.00 |
| 52 Week Low | US$3,970.00 |
| Beta | 0.51 |
| 1 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -20.10% |
Recent News & Updates
Recent updates
Shareholder Returns
| CVS | AR Healthcare | AR Market | |
|---|---|---|---|
| 7D | -16.9% | 0% | 0% |
| 1Y | n/a | 0% | 0% |
Return vs Industry: Insufficient data to determine how CVS performed against the AR Healthcare industry.
Return vs Market: Insufficient data to determine how CVS performed against the AR Market.
Price Volatility
| CVS volatility | |
|---|---|
| CVS Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 0% |
| Market Average Movement | 0% |
| 10% most volatile stocks in AR Market | 0% |
| 10% least volatile stocks in AR Market | 0% |
Stable Share Price: CVS's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine CVS's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 259,500 | Karen Lynch | www.cvshealth.com |
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
CVS Health Corporation Fundamentals Summary
| CVS fundamental statistics | |
|---|---|
| Market cap | AR$62.08t |
| Earnings (TTM) | AR$6.43t |
| Revenue (TTM) | AR$315.87t |
9.5x
P/E Ratio0.2x
P/S RatioIs CVS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CVS income statement (TTM) | |
|---|---|
| Revenue | US$359.66b |
| Cost of Revenue | US$307.32b |
| Gross Profit | US$52.34b |
| Other Expenses | US$45.02b |
| Earnings | US$7.32b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 5.83 |
| Gross Margin | 14.55% |
| Net Profit Margin | 2.04% |
| Debt/Equity Ratio | 86.5% |
How did CVS perform over the long term?
See historical performance and comparison